These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9454886)

  • 41. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC).
    Schmid M; Malicki D; Nobori T; Rosenbach MD; Campbell K; Carson DA; Carrera CJ
    Oncogene; 1998 Nov; 17(20):2669-75. PubMed ID: 9840931
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.
    Balázs M; Carroll P; Kerschmann R; Sauter G; Waldman FM
    Genes Chromosomes Cancer; 1997 Jun; 19(2):84-9. PubMed ID: 9171998
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer.
    Williamson MP; Elder PA; Shaw ME; Devlin J; Knowles MA
    Hum Mol Genet; 1995 Sep; 4(9):1569-77. PubMed ID: 8541841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Relationship between p16 and Rb protein expression in astrocytomas].
    Lin Y; Huang C; Liu D
    Zhonghua Bing Li Xue Za Zhi; 1997 Dec; 26(6):340-2. PubMed ID: 10374322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inactivation of p16/CDKN2 and p15/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer.
    Kudoh K; Ichikawa Y; Yoshida S; Hirai M; Kikuchi Y; Nagata I; Miwa M; Uchida K
    Int J Cancer; 2002 Jun; 99(4):579-82. PubMed ID: 11992549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer.
    Jarrard DF; Bova GS; Ewing CM; Pin SS; Nguyen SH; Baylin SB; Cairns P; Sidransky D; Herman JG; Isaacs WB
    Genes Chromosomes Cancer; 1997 Jun; 19(2):90-6. PubMed ID: 9171999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Analysis on point mutation of the CDKN2/p16 gene in lung cancer].
    Su C; Ye Y; Wang D; Cao X; Li S; Shan X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):37-40. PubMed ID: 11836684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular analysis of CDKN2 (p16) in gliomas associated with clinical data.
    De Souza Nascimento P; Maciel CM; Kawamura MT; Oliveira JA; Teixeira A; Carvalho Mda G; Alves G
    Oncol Rep; 2001; 8(5):1039-43. PubMed ID: 11496313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
    Herman JG; Merlo A; Mao L; Lapidus RG; Issa JP; Davidson NE; Sidransky D; Baylin SB
    Cancer Res; 1995 Oct; 55(20):4525-30. PubMed ID: 7553621
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inactivation of p16/CDKN2 and p15/MTS2 genes in different histological types and clinical stages of primary ovarian tumors.
    Ichikawa Y; Yoshida S; Koyama Y; Hirai M; Ishikawa T; Nishida M; Tsunoda H; Kubo T; Miwa M; Uchida K
    Int J Cancer; 1996 Dec; 69(6):466-70. PubMed ID: 8980248
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Study of p16INK4/CDKN2 gene homozygous deletions and point mutation in squamous cell carcinoma of buccal mucosa].
    Dong YY; Wang J; Dong FS; Wang X; Zhang YH; Guo LH
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2006 Aug; 24(4):362-5. PubMed ID: 16999361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma.
    Merbs SL; Sidransky D
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):779-83. PubMed ID: 10067984
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alteration of p16 and p15 genes in human uterine tumours.
    Nakashima R; Fujita M; Enomoto T; Haba T; Yoshino K; Wada H; Kurachi H; Sasaki M; Wakasa K; Inoue M; Buzard G; Murata Y
    Br J Cancer; 1999 May; 80(3-4):458-67. PubMed ID: 10408854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical analysis of cyclin A in astrocytic tumours.
    Chakrabarty A; Bridges LR
    Neuropathol Appl Neurobiol; 1998 Jun; 24(3):239-45. PubMed ID: 9717190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
    Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
    Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.
    Maelandsmo GM; Berner JM; Flørenes VA; Forus A; Hovig E; Fodstad O; Myklebost O
    Br J Cancer; 1995 Aug; 72(2):393-8. PubMed ID: 7640224
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple suppressor gene p16 of human brain gliomas.
    Shu H; Zhou D; Li Z; Lin Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Dec; 36(7):517-8. PubMed ID: 12411158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
    Sonoda Y; Yoshimoto T; Sekiya T
    Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
    Wiest JS; Franklin WA; Otstot JT; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain JW; Anderson MW
    Cancer Res; 1997 Jan; 57(1):1-6. PubMed ID: 8988029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry.
    Purkait S; Jha P; Sharma MC; Suri V; Sharma M; Kale SS; Sarkar C
    Neuropathology; 2013 Aug; 33(4):405-12. PubMed ID: 23311918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.